Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug ...

Thus, Zenocutuzumab is a promising bet for the treatment of advanced non-small-cell lung cancer and pancreatic cancer with NRG1 fusion. Because it aims at deactivating proteins which are a unique ...

More people have died of lung cancer in the Channel Islands than any other type of cancer, according to a new NHS report. The National Disease Registration Service (NDRS), part of NHS England ...

Bryant Lin has been diagnosed with stage 4 lung cancer despite never smoking in his life. The oncologist, per the Stanford Medicine blog Scope, was diagnosed with non-small cell cancer — also ...

AstraZeneca’s IMFINZI ® (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed ...

December 05, 2024--(BUSINESS WIRE)--AstraZeneca’s IMFINZI ® (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC ...

IMFINZI® (durvalumab) approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer Based on ADRIATIC Phase III trial results which showed a 27 ...

The FDA has granted accelerated approval to zenocutuzumab, a new drug for adults with advanced non-small-cell lung cancer (NSCLC ... tiredness, rashes, infusion reactions, breathing trouble ...

“Unfortunately, some growths tend to be mistaken for moles when they’re actually melanoma, a form of skin cancer that begins in the melanocytes, or the cells responsible for producing ...

Three and a half years ago, Alison Tatum was diagnosed with stage four lung cancer and told she had between 12 and 18 months to live. Her oncologist has called her "a walking miracle", as she is ...